530 related articles for article (PubMed ID: 9804332)
1. Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa.
Terracina M; Posteraro P; Schubert M; Sonego G; Atzori F; Zambruno G; Bruckner-Tuderman L; Castiglia D
J Invest Dermatol; 1998 Nov; 111(5):744-50. PubMed ID: 9804332
[TBL] [Abstract][Full Text] [Related]
2. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
[TBL] [Abstract][Full Text] [Related]
3. Modulation of disease severity of dystrophic epidermolysis bullosa by a splice site mutation in combination with a missense mutation in the COL7A1 gene.
Winberg JO; Hammami-Hauasli N; Nilssen O; Anton-Lamprecht I; Naylor SL; Kerbacher K; Zimmermann M; Krajci P; Gedde-Dahl T; Bruckner-Tuderman L
Hum Mol Genet; 1997 Jul; 6(7):1125-35. PubMed ID: 9215684
[TBL] [Abstract][Full Text] [Related]
4. Compound heterozygosity for a nonsense mutation and a splice site mutation in the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa.
Tamai K; Ishida-Yamamoto A; Matsuo S; Iizuka H; Hashimoto I; Christiano AM; Uitto J; McGrath JA
Lab Invest; 1997 Feb; 76(2):209-17. PubMed ID: 9042157
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological correlations of compound heterozygous COL7A1 mutations in recessive dystrophic epidermolysis bullosa.
Dunnill MG; McGrath JA; Richards AJ; Christiano AM; Uitto J; Pope FM; Eady RA
J Invest Dermatol; 1996 Aug; 107(2):171-7. PubMed ID: 8757758
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation.
Hovnanian A; Rochat A; Bodemer C; Petit E; Rivers CA; Prost C; Fraitag S; Christiano AM; Uitto J; Lathrop M; Barrandon Y; de Prost Y
Am J Hum Genet; 1997 Sep; 61(3):599-610. PubMed ID: 9326325
[TBL] [Abstract][Full Text] [Related]
7. A combination of a common splice site mutation and a frameshift mutation in the COL7A1 gene: absence of functional collagen VII in keratinocytes and skin.
Hammami-Hauasli N; Kalinke DU; Schumann H; Kalinke U; Pontz BF; Anton-Lamprecht I; Pulkkinen L; Zimmermann M; Uitto J; Bruckner-Tuderman L
J Invest Dermatol; 1997 Sep; 109(3):384-9. PubMed ID: 9284109
[TBL] [Abstract][Full Text] [Related]
8. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
[TBL] [Abstract][Full Text] [Related]
9. Dominant dystrophic epidermolysis bullosa (Pasini) caused by a novel glycine substitution mutation in the type VII collagen gene (COL7A1).
Jonkman MF; Moreno G; Rouan F; Oranje AP; Pulkkinen L; Uitto J
J Invest Dermatol; 1999 May; 112(5):815-7. PubMed ID: 10233777
[TBL] [Abstract][Full Text] [Related]
10. Three homozygous PTC mutations in the collagen type VII gene of patients affected by recessive dystrophic epidermolysis bullosa: analysis of transcript levels in dermal fibroblasts.
Gardella R; Zoppi N; Ferraboli S; Marini D; Tadini G; Barlati S; Colombi M
Hum Mutat; 1999; 13(6):439-52. PubMed ID: 10408773
[TBL] [Abstract][Full Text] [Related]
11. Compound heterozygosity for COL7A1 mutations in twins with dystrophic epidermolysis bullosa: a recessive paternal deletion/insertion mutation and a dominant negative maternal glycine substitution result in a severe phenotype.
Christiano AM; Anton-Lamprecht I; Amano S; Ebschner U; Burgeson RE; Uitto J
Am J Hum Genet; 1996 Apr; 58(4):682-93. PubMed ID: 8644730
[TBL] [Abstract][Full Text] [Related]
12. Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa.
Christiano AM; Anhalt G; Gibbons S; Bauer EA; Uitto J
Genomics; 1994 May; 21(1):160-8. PubMed ID: 8088783
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mutations of the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa mitis (M-RDEB) from three Korean patients.
Ryoo YW; Kim BC; Lee KS
J Dermatol Sci; 2001 Jun; 26(2):125-32. PubMed ID: 11378329
[TBL] [Abstract][Full Text] [Related]
14. Glycine substitution mutations in the type VII collagen gene (COL7A1) in dystrophic epidermolysis bullosa: implications for genetic counseling.
Kon A; McGrath JA; Pulkkinen L; Nomura K; Nakamura T; Maekawa Y; Christiano AM; Hashimoto I; Uitto J
J Invest Dermatol; 1997 Feb; 108(2):224-8. PubMed ID: 9008239
[TBL] [Abstract][Full Text] [Related]
15. A de novo glycine substitution mutation in the collagenous domain of COL7A1 in dominant dystrophic epidermolysis bullosa.
Lee JY; Li C; Chao SC; Pulkkinen L; Uitto J
Arch Dermatol Res; 2000 Apr; 292(4):159-63. PubMed ID: 10836608
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
Dang N; Murrell DF
Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
[TBL] [Abstract][Full Text] [Related]
17. The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa.
Nakamura H; Sawamura D; Goto M; Sato-Matsumura KC; LaDuca J; Lee JY; Masunaga T; Shimizu H
J Dermatol Sci; 2004 May; 34(3):195-200. PubMed ID: 15113589
[TBL] [Abstract][Full Text] [Related]
18. A glycine-to-arginine substitution in the triple-helical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa.
Christiano AM; Morricone A; Paradisi M; Angelo C; Mazzanti C; Cavalieri R; Uitto J
J Invest Dermatol; 1995 Mar; 104(3):438-40. PubMed ID: 7861014
[TBL] [Abstract][Full Text] [Related]
19. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
Turczynski S; Titeux M; Tonasso L; Décha A; Ishida-Yamamoto A; Hovnanian A
J Invest Dermatol; 2016 Dec; 136(12):2387-2395. PubMed ID: 27498345
[TBL] [Abstract][Full Text] [Related]
20. Transient bullous dermolysis of the newborn associated with compound heterozygosity for recessive and dominant COL7A1 mutations.
Hammami-Hauasli N; Raghunath M; Küster W; Bruckner-Tuderman L
J Invest Dermatol; 1998 Dec; 111(6):1214-9. PubMed ID: 9856844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
